Hepatitis C is a viral infection that causes liver inflammation, potentially leading to severe liver damage. Globally, over 150 million individuals could be unknowingly harbouring the highly contagious hepatitis C virus, often referred to as a ‘silent killer’ due to its gradual progression and lack of noticeable symptoms until significant liver damage has occurred. In the UK alone, an estimated 118,000 people had chronic hepatitis C in 2019. The virus can result in serious health complications such as cardiovascular disease, mental health problems, kidney disease, and musculoskeletal pain. Typically, symptoms do not manifest until the infection progresses to liver disease, with common signs including fatigue and difficulty concentrating.
Fortunately, there are effective antiviral medications available that can cure over 95% of cases with minimal side effects, potentially eradicating the virus. Hepatitis C is primarily transmitted through contact with the blood of an infected person. Many individuals infected with hepatitis C are unaware of their condition as symptoms may not appear until significant liver damage has occurred, which can be mistaken for other conditions. Testing is the only reliable way to confirm a hepatitis C infection.
In the UK, the majority of hepatitis C infections occur in individuals who inject drugs or have a history of drug injection. The NHS highlights the importance of addressing the virus promptly, as untreated hepatitis C can lead to serious and life-threatening liver damage over time. It can be easily tested through a simple finger-prick blood test, with treatment options available through the NHS, providing a straightforward process for diagnosis and management.
Thanks to a proactive approach and a significant investment in antiviral drugs, the NHS in England is on track to eliminate hepatitis C by 2025, exceeding global targets. The initiative has seen a 35% decrease in deaths related to hepatitis C, including liver disease and cancer. The effort to identify those at risk and provide accessible testing and treatment showcases the commitment to combatting hepatitis C and improving public health.
In conclusion, raising awareness about hepatitis C, promoting testing among at-risk populations, and ensuring access to effective treatment are crucial steps in combating this viral infection and preventing long-term complications. Early detection and intervention play a vital role in managing hepatitis C and reducing its impact on individuals and public health. Efforts to eliminate hepatitis C demonstrate the importance of proactive healthcare strategies in addressing infectious diseases and improving outcomes for patients.